A detailed history of Wolverine Trading, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 61,900 shares of OCGN stock, worth $50,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,900
Holding current value
$50,139
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.5 - $1.83 $11,764 - $43,056
23,528 New
23,528 $38,000
Q2 2022

Aug 15, 2022

SELL
$1.83 - $3.45 $18,321 - $34,541
-10,012 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.34 - $4.72 $23,428 - $47,256
10,012 New
10,012 $34,000
Q4 2021

Feb 14, 2022

SELL
$4.38 - $15.67 $143,532 - $513,505
-32,770 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$6.36 - $8.51 $71,435 - $95,584
11,232 Added 52.15%
32,770 $223,000
Q2 2021

Aug 06, 2021

BUY
$5.52 - $15.68 $118,889 - $337,715
21,538 New
21,538 $182,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $175M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.